Publications found:
253,269
Sort by:
China's Pharmaceutical Industry 2011
US$ 600.00
This report describes the general development of China’s pharmaceutical industry in aspects of investment, production, sales, import & export, major prices and operations.
April 2012
15 pages
Smoking Cessation Drugs: World Market Prospects 2012-2022
US$ 2,633.00
... . R&D is promising. New formulations and generics will be important too. Innovations in drug delivery and rising demand in developing countries will also stimulate ... , 29 charts and three research interviews. Eight ways Smoking Cessation Drugs: World Market Prospects 2012-2022 helps you In particular, our ...
April 2012
116 pages
Merck - Celltrion filed first mAB Biosimilar in Europe: Remicade Challenged
US$ 90.00
Celltrion filed infliximab biosimilar (CT-P13) in Europe and was accepted for review by EMA. It is the first biosimilar mAb to be filed for approval in Europe. The patent ... Celltrion conducted PhI and PhIII clinical trials with the duration of 12 months in more than 850 patients. It has already filed Infliximab ...
April 2012
1 pages
Medicated Skin Care in Hong Kong, China
US$ 990.00
... occurrences of skin diseases or symptoms in Hong Kong will continue to see growth in medicated skin care due to stressful lifestyle, diseases, erratic weather conditions, etc. Euromonitor International's Medicated Skin Care in Hong Kong, China ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
20 pages
Clinical Trials Market in India 2012
US$ 950.00
... into the market and highlights the market size and growth of clinical trials in the country. India’s current and projected share in the global clinical trials market has also ...
April 2012
58 pages
Medicated Skin Care in Ecuador
US$ 990.00
... any measures to prevent the consequences. This has... Euromonitor International's Medicated Skin Care in Ecuador report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
22 pages
Emergency Contraception in Belarus
US$ 990.00
... be used under medical supervision. Most of the hormonal contraceptive medicines in Belarus are Rx products. Euromonitor International's Emergency Contraception in Belarus report offers a comprehensive guide to the size ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
April 2012
19 pages
Medicated Skin Care in Belarus
US$ 990.00
... . Rising urban population and stress levels in Belarus also resulted in an increase in the incidence of skin... Euromonitor International's Medicated Skin Care in Belarus report offers a comprehensive guide to the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
35 pages
NRT Smoking Cessation Aids in Belarus
US$ 990.00
... to lower the smoking rate. Heart disease accounts for some 88% of deaths from smoking-related illnesses in Belarus. Other... Euromonitor International's NRT Smoking Cessation Aids in Belarus report offers a comprehensive ... data. Why buy this report? Get a detailed picture of the NRT Smoking Cessation Aids market; Pinpoint growth sectors and identify factors driving change ...
April 2012
24 pages
Weight Management in Belarus
US$ 900.00
... to obesity products, which are only available in... Euromonitor International's Weight Management in Belarus report offers a comprehensive guide to the size and shape ... data. Why buy this report? Get a detailed picture of the Weight Management market; Pinpoint growth sectors and identify factors driving ...
April 2012
23 pages
Medicated Skin Care in Turkey
US$ 990.00
... are usually cosmetic products rather than medicines. Euromonitor International's Medicated Skin Care in Turkey report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
28 pages
Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
US$ 3,700.00
... to Susan Eustis, lead author of the study, 'Reimbursement drives power wheelchair markets'. As people and governments pay for medical insurance more money ... , permitting the patient to control mobility for the rehabilitation efforts. Power wheel chairs give patients the ability to control movement. Transport ...
April 2012
467 pages
REGENERON: Tapping Other TRAPS in 3Q12 - ZALTRAP and ARCALYST!
US$ 90.00
... with Bayer for Ex-US, wet AMD) launch skyrocketed Regeneron (REGN); we expect other TRAP based products in the pipeline to sustain this ... Sanofi granted A Priority Review for ZALTRAP (VEGF trap/ aflibercept, R, mCRC – 2nd-line; PhII/ ... 5, 2012 on REGN, titled “Tapping Other TRAPS in 3Q12 - ZALTRAP and ARCALYST!”
April 2012
5 pages
Medicated Skin Care in France
US$ 990.00
... drugs and Rx medicines because they are reimbursed. Euromonitor International's Medicated Skin Care in France report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
42 pages
New Product Developments in Consumer Health
US$ 2,000.00
... exploring new delivery mechanisms and formulas to stand out. Euromonitor International’s New Product Developments in Consumer Health global briefing examines the size, growth trends and potential opportunities in the Consumer Health market. The strategic analyses include assessing the impacts of ...
April 2012
43 pages
Medicated Skin Care in the US
US$ 990.00
... diapers, which increases the incidence of diaper rash. Euromonitor International's Medicated Skin Care in USA report offers a comprehensive guide to the size and shape ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
53 pages
Healthcare Industry Deal Directory - Edition Q4'2011
US$ 350.00
The healthcare database provides access to all the Mergers and Acquisitions (M&A), Private Equity and Venture Capital Deals since 2004. The database is categorized into various sub-sectors includi...
April 2012
Computed Tomography (CT) Systems: Global Market Outlook 2012-2022
US$ 2,635.00
... review of companies and leading products. Why you should buy Computed Tomography (CT) Systems: Global Market Outlook 2012-2022 In this report, you ... the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the CT systems market from 2012 onwards You will be able to investigate competition ...
April 2012
117 pages
U.S. Market for Gastrointestinal Endoscopic Devices 2012
US$ 7,495.00
... will result in growth returning to pre-recession levels by 2018. Within the gastrointestinal endoscopic device market, companies such as Boston Scientific, Cook Medical, Given Imaging, Olympus and Pentax lead the market, among many others. This report provides a comprehensive and detailed analysis ...
April 2012
457 pages
Asia Pacific Markets for Women’s Health Devices 2012
US$ 8,495.00
In 2011, the total market for the Asia-Pacific women’s health devices was valued at over $790 million. The main conditions dealt ... Japan Australia. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, ...
April 2012
596 pages
Asia-Pacific Markets for Vascular Access Devices and Accessories 2012 (3 Countries)
US$ 7,495.00
The vascular access devices market in the Asia-Pacific region encompass implantable ports, port needles, central venous catheters, ... intravenous catheters. The Asia-Pacific vascular access devices market report analyzes and evaluates the current state of the market including existing and potential markets, product average ...
April 2012
205 pages
Global Drugs Retail Industry 2012 - 2017: Trend, Profit, and Forecast Analysis
US$ 1,980.00
... the Global Drug Retail market and presents its findings in “Global Retail Drug Industry 2012-2017: Trend, Profit, and Forecast Analysis.” The drug industry consists of pharmacies and drug ... (Q1 2012 – Q4 2012) for global drugs retail industry analysis Gross and net profit trends in the global drugs retail industry analysis Cost structure trend in the global as well as regional global drugs retail industry ...
April 2012
Global Home Healthcare Device Industry 2012 - 2017: Trend, Profit, and Forecast Analysis
US$ 1,980.00
... the face of global home healthcare device industry. Lucintel’s study provides a concise overview of the global home healthcare device industry. The report tracks four regions of global home healthcare device industry. This study ... ) for global home healthcare device industry analysis Gross and net profit trends in the global home healthcare device industry analysis Cost structure trend in the global as well as regional home healthcare device industry ...
April 2012
UAE Healthcare Sector Forecast to 2014
US$ 1,200.00
In the past few years, the UAE healthcare industry has shown an unprecedented growth which is expected to continue in the future due to increasing population, rising prevalence of lifestyle diseases a...
March 2012
135 pages
Saudi Arabian Healthcare Forecast to 2015
US$ 1,000.00
Saudi Arabia represents the largest healthcare market in the GCC region that possesses a huge potential for further expansion due to rising healthcare needs. The government and health regulatory autho...
March 2012
115 pages
Biotechnology Reagents: Market Research Report
US$ 4,500.00
... analyzes the worldwide markets for Biotechnology Reagents in US$ Million by the following Product Segments: Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis ... Diagnostics Ltd., Siemens Healthcare Diagnostics, Inc., and Sigma - Aldrich. Market data and analytics are derived from primary and secondary ...
March 2012
925 pages
G-Protein Coupled Receptors (GPCRs): Market Research Report
US$ 4,500.00
This report analyzes the Global market for G-Protein Coupled Receptors (GPCRs) in US$ Billion. Annual estimates and forecasts are provided for ... through 2017. Also, a six-year historic analysis is provided for this market. The report profiles 43 companies including 7TM Pharma A/S, Actelion Pharmaceuticals ...
March 2012
299 pages
Global RNAi Market Analysis
US$ 1,200.00
RNA Interference (RNAi) has emerged as a breakthrough in the life sciences industry. It presents an extensive potential in multiple areas, such as drug discovery, drug development, and therapeutic app...
March 2012
105 pages
Anxiety Disorders: Market Research Report
US$ 4,800.00
This report analyzes the worldwide markets for Anxiety Disorders in US$ Million. The report provides separate comprehensive analytics for the US, Europe, ... , Sanofi, UCB SA, Valeant Pharmaceuticals International, and Watson Laboratories, Inc. Market data and analytics are derived from primary and secondary ...
March 2012
615 pages
Herpes Simplex Virus Treatment: Market Research Report
US$ 4,600.00
This report analyzes the worldwide markets for Herpes Simplex Virus Treatment in US$ Million. The report provides separate comprehensive analytics for the US, ... , Inc., Novartis International AG, Sanofi, Starpharma Holdings Limited, and Vical. Market data and analytics are derived from primary and secondary ...
March 2012
300 pages
RNA Interference (RNAi): Market Research Report
US$ 4,800.00
This report analyzes the worldwide markets for RNA Interference (RNAi) in US$ Million by the following Application Areas: Drug Discovery and Target ... , Inc., Exiqon A/S, Genesis Research & Development Corporation Limited, Halo-Bio RNAi Therapeutics, Inc., Marina Biotech, Inc., OPKO Health, Inc., Polyplus- ...
March 2012
792 pages
Global Protein Therapeutics Market Forecast to 2015
US$ 1,800.00
Protein-based therapies have found a prominent place in the biopharmaceutical industry since the launch of human insulin product. They have become one of the most effective clinical methods to treat w...
March 2012
160 pages
Therapy Trends: Multiple Sclerosis
US$ 4,995.00
An incisive report and dynamic analyst briefing service delivering insight from the most influential Multiple Sclerosis (MS) Key Opinion Leaders to map the current treatment landscape and analyse futu...
March 2012
160 pages
Branded Generics in South East Asia: Current and Future Opportunities
US$ 945.00
... launching their branded generic brands but I can't say for sure that success is guaranteed in South East Asia.” – Dr. Suchitra Kataria, former Head of Business Development and In-Licensing - Regional Strategic Development Asia Pacific at Bayer ...
March 2012
78 pages
Market Access: Communicating Value Stories to Payers
US$ 595.00
... affiliate organisations. What strategies are emerging to tackle these challenges? Market Access: Communicating Value Stories to Payers shares up-to-the-minute insights and case studies from ... finding their way through this new environment. Report Overview Market Access: Communicating Value Stories to Payers provides unique, practical insights into how companies can ...
March 2012
46 pages
Generics as a Vehicle to Improve Market Access
US$ 695.00
In low and middle-income countries, around 17.6 million people each year die of treatable infectious diseases, reproductive health issues, and childhood illnesses. Millions more experience poor qualit...
March 2012
79 pages
Magnetic Resonance Imaging (MRI) Systems: Global Market Outlook 2012-2022
US$ 2,635.00
... has led to financial cuts in the healthcare sector in many countries, the MRI market remains solid with strong opportunities especially in emerging countries such ... companies and leading products. Why you should buy Magnetic Resonance Imaging (MRI) Systems: Global Market Outlook 2012-2022 In this report, ...
March 2012
108 pages
Roche - GSK - EMILIA: TDM1 ready to take over Tykerb
US$ 90.00
Today, Roche and ImmunoGen announced the topline data from EMILIA study ... T-DMI in this indication and this should come at the expense of GSK’s Tykerb, which is the current standard of care in this setting. This ...
March 2012
3 pages
